News Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Delayed NSE India S.E. Other stock markets 09:07:26 14/05/2024 BST			5-day change	1st Jan Change
303.1 ^INR	+2.85%		-2.37%	-25.39%

03-19	Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	MT
03-08	Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	03-19	MT
Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	03-08	MT
Venus Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Venus Remedies Gets Ukraine Marketing Approval for Chemotherapy Drug, Antibiotics	02-13	MT
Venus Remedies Gets Marketing Authorization in Malta for Two Chemotherapy Drugs	01-12	MT
Venus Remedies Gets Authorization to Market Cancer Drugs in Israel, Colombia	12-21	MT
Indian Equities Clock Sharp Losses on Wednesday Due to Widespread Selling	12-20	MT
Venus Remedies Expands Into Wellness Business	12-20	MT
Venus Remedies Gets Bahrain Marketing Authorization for Enoxaparin	12-19	MT
Indian Equities Score Another Record Highs on Tuesday, Lifted by Ruling Party's State Polls Win	12-05	MT
Venus Remedies Gets Azerbaijan's Marketing Approval for Blood Clot Prevention Drug	12-05	MT
Venus Remedies Gets Marketing Approval for Cancer Drugs in Philippines, Saudi Arabia	12-01	MT
Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and Philippines	12-01	CI
Venus Remedies' Consolidated Profit Jumps in Fiscal Q2	11-27	MT
Venus Remedies Arm Gets Authorization to Market Cancer Drug in UK	26/10/23	MT
Venus Remedies Secures Marketing Approval for Six Key Chemotherapy Drugs in Philippines	16/10/23	MT
Venus Remedies Limited Receives Marketing Approval from the Philippines for Six Key Chemotherapy Drugs	16/10/23	CI
Venus Remedies Launches Antibiotic Elores in Ecuador	12/10/23	MT
Venus Remedies Limited Expands Global Reach with the Launch of Elores in Ecuador	12/10/23	CI
Venus Remedies Gets Marketing Authorization from Serbia for Chemotherapy Drugs	20/09/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Summary

Filters